Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Ackroo Announces 2023 Audited Financial Results
-
Biora Therapeutics Announces Completion of Multiple-Ascending Dose (MAD) Cohorts for Clinical Trial of BT-600
-
Shape Therapeutics to Showcase RNA Editing in the Brain and Validation of their Stable AAV Producer Cell Line at ASGCT 2024
-
Banco Santander-Chile Announces First Quarter 2024 Earnings
-
In Vivo Efficacy of Matinas BioPharma’s Oral MAT2203 in Pulmonary Mucormycosis Published in Journal of Antimicrobial Agents and Chemotherapy
-
Federated Wireless Announces Major Enhancements to its Class-Leading CBRS Shared Spectrum Offering
-
Armstrongs, A Becklar Company, Debuts State-of-the-Art Critical Event Monitoring and Data Centre in Quebec
-
American Oncology Network Announces First Quarter 2024 Earnings Release Date and Conference Call
-
INmune Bio Inc. Provides Update on Two Patients from the Phase 1b Alzheimer’s Disease Trial who Continue to Receive XPro™ Under Compassionate Use for Over Three Years
-
Altitude Lab Secures Small Business Administration Growth Fund Accelerator Grant to Launch Horizon, a Commercialization Partnering Program
-
Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer
-
Acceptance of Eflornithine (DFMO) Abstract for Oral Presentation at Digestive Disease Week
-
Alignment Healthcare to Present at Two Investor Conferences in May 2024
-
VERSES Closes Additional Tranche for C$9.3M Aggregate Proceeds under Private Placement
-
Sysco Announces CEO Kevin Hourican Has Been Appointed Chair of the Board and Chief Executive Officer
-
Jayud Global Logistics Announces Entry into the North American Market with the Acquisition of HYTX Warehouse Inc.
-
SEALSQ Continues to Make Progress on Post-Quantum Engineering Roadmap and Leverages New Hardware Platform to Develop Custom Application Specific ICs (ASICs)
-
FactSet Introduces AI-Powered Portfolio Commentary
-
Eagle Pharmaceuticals Announces a Trial in Progress Presentation of Phase 2/3 Study of Intravenous Amisulpride as Prevention of Postoperative Nausea and Vomiting in Pediatric Patients at the Upcoming
-
Lundquist Investigator Dr. Ashraf Ibrahim Is the Lead Author in the Landmark Study on Pioneering Oral Fungal Infection Treatment Showing Promise in Preclinical Trials
-
Duos Technologies Group Announces CFO Transition and Strategic Growth Focus
-
YPrime Launches Intuitive Tender Swollen Joint Count (TSJC) Assessment for Effortless eCOA
-
Route 92 Medical Announces FDA 510(k) Clearance for FreeClimb 54 Reperfusion System
-
As Consumers’ Debt Burdens Rise, Government Agencies Have Opportunities to Better Assist Them with Key Services
-
New Funding from the Charles Stewart Mott Foundation Will Expand Youth Service Infrastructure in Eight States
-
LM Funding America, Inc. Announces the Appointment of Marty Traber to its Board of Directors
-
Truvaga™ Plus Demonstrates Health Benefits in Latest Consumer Study, Paving the Way for Market Expansion
-
Sysco Reports Third Quarter Operating Income and EPS Growth
-
Nautilus Biotechnology Reports First Quarter 2024 Financial Results
-
Inspire Medical Systems, Inc. to Present at the BofA Securities 2024 Health Care Conference
-
Alimera Sciences to Report First Quarter 2024 Financial Results on May 14, 2024, and Provide Corporate Update
-
Pacira to Report First Quarter 2024 Financial Results on Tuesday May 7, 2024
-
New research reveals only a handful of organisations can access sensitive data in a timely manner
-
Utenos Trikotažas Group Recorded EUR 3.1 Million in Revenue for the First Quarter of the Year
-
Study: This Brain Training Resulted in Better Performance and Less Atrophy in the Brain
-
UltiSat and CloudJuncxion Partner to Simplify Software Defined Networking for Tactical Missions
-
Notice on the convened Ordinary General Meeting of Shareholders of AB “KN Energies”
-
MAOCAT Launches First Presale on Ethereum for Cat-Based Memecoin
-
Mobile-health Network Solutions Opens New Retail Pharmacy
-
Complete Solaria to Report Fourth Quarter 2023 and First Quarter 2024 Financial and Operational Results on May 2, 2024
-
Huhtamäki Oyj - Managers' Transactions (Pauni)
-
Kaspi.kz Announces Partnership with Alipay+ for QR payments across China
-
Robex Reports 2023 Financial Results
-
Form 8.3 - Gresham Technologies Plc
-
Form 8.3 - [LOK'N STORE GROUP PLC - 29 04 2024] - (CGWL)
-
Alliance Trust PLC - Net Asset Value
-
Form 8.3 - [abrdn EUROPEAN LOGISTICS INCOME PLC - 29 04 2024] - (CGWL)
-
Middlefield Banc Corp. Reports 2024 First Quarter Financial Results
-
Postal Realty Trust Declares First Quarter 2024 Dividend
-
Applied Materials Announces Q2 FY2024 Earnings Webcast and CY2023 WFE Market Summary


